Looks like thats it. Between current assets and current liabilities they will fall almost 3 million short meaning the creditors will get the patents as I don't see anybody buying the company. The final insult is Chris Schnarr pretending shareholders might still have a say in voting on the sale of the company. This is a first for me in all the years I've invested in the stock market and god willing the last time I have to go through something like this. Bitter pill to take and hopefully I can make back some of my losses in the years to come. My regards to all those that lost money on what was never meant to be. 

 

http://www.stockhouse.com/news/press-releases/2013/08/16/bioexx-announces-q2-2013-results